As part of the collaboration, PNM will leverage the clinical workflow and collaboration engine, Snke Cockpits, to manage complex treatment planning workflows in the cloud. Snke Cockpits enable structured case coordination, transparent collaboration, and secure data exchange—connecting stakeholders across institutions in a seamless, digitally integrated environment.

In addition, Snke and PNM agreed to establish a data-driven clinical registry designed to systematically capture imaging, planning, procedure, and outcome data for targeted drug delivery treatments. By combining workflow management with structured real-world data collection, the partnership aims to accelerate learning cycles in precision drug delivery and to create a scalable foundation for future therapies on the central nervous system (CNS).

“Precision therapies require precision workflows,” said Stefan Vilsmeier, Founder and CEO of Snke. “With Snke Cockpits, we are building the digital backbone that connects clinicians, experts, and data—always with the patient at the center.”

“Delivering advanced CNS therapies is not just about biology—it’s about coordination, data and continuous improvement,” said Sandeep Kunwar, MD, Founder and CEO of PNM. “Partnering with Snke allows us to operationalize excellence and build a high-quality data foundation for the future of precision brain therapies.”

The collaboration reflects a shared ambition to combine therapeutic innovation with modern digital infrastructure—enabling better decisions, higher treatment quality, and scalable clinical impact.